leadf
logo-loader
viewVonex Ltd
(
ASX:VN8
)

Full interview: Vonex records strongest April in the company’s history for retail business

Vonex (ASX: VN8) CEO Matt Fahey joined Proactive’s Steve Darling with news the company has seen incredible growth in the company, in fact, annualised recurring revenue grew by more than 85%. Fahey talks about what is leading that revenue growth and also about the launch of their app Oper8tor.

Quick facts: Vonex Ltd

Follow
ASX:VN8

Price: 0.125 AUD

Market Cap: $40.74 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

MGC Pharmaceuticals: Continuous global breakthroughs as progress accelerates

Proactive Research Analyst Ed Stacey presents his analysis on MGC Pharmaceuticals (LON:MXC).  The company recently announced that it has received a UK import permit for CannEpil+, which is MGC’s cannabis-derived therapy for refractory epilepsy, to be used initially on a compassionate access...

15 hours, 56 minutes ago

2 min read